CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In- Capital	Treasury Stock	Accumulated Deficit	Noncontrolling Interest
Balances at beginning of period at Dec. 31, 2020	$ 802,729	$ 1,983	$ 4,212,409	$ (102,774)	$ (3,311,184)	$ 2,295
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to restricted stock grants			16,270
Issuance of common stock under Associate Stock Purchase Plan			699
Purchase of capped call transactions			(15,916)
Restricted stock and restricted stock units, net		(1)	1
Shares withheld for employee taxes		(7)	(4,813)
Other, net			25
Net income (loss)	(99,290)				(99,290)
Net income (loss) attributable to noncontrolling interest	(99,364)					(74)
Balances at end of period at Dec. 31, 2021	699,623	$ 1,975	4,208,675	(102,774)	(3,410,474)	2,221
Balances at beginning of period (in shares) at Dec. 31, 2020		187,804,000
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Issuance of common stock under Associate Stock Purchase Plan (in shares)		124,000
Restricted stock and restricted stock units, net (in shares)		(159,000)
Shares withheld for employee taxes (in shares)		(811,000)
Balances at end of period (in shares) at Dec. 31, 2021		186,958,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to restricted stock grants			14,466
Issuance of tangible equity units, net of issuance costs			113,457
Restricted stock and restricted stock units, net		$ 9	(9)
Shares withheld for employee taxes		(6)	(4,287)
Net income (loss)	(238,427)				(238,427)
Net income (loss) attributable to noncontrolling interest	(238,340)					87
Noncontrolling interest distribution						(760)
Balances at end of period at Dec. 31, 2022	$ 584,153	$ 1,978	4,332,302	(102,774)	(3,648,901)	1,548
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Restricted stock and restricted stock units, net (in shares)		911,000
Shares withheld for employee taxes (in shares)		(620,000)
Balances at end of period (in shares) at Dec. 31, 2022	187,249,466	187,249,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to restricted stock grants			11,985
Restricted stock and restricted stock units, net		$ 16	(16)
Shares withheld for employee taxes		(6)	(1,909)
Net income (loss)	$ (189,011)				(189,011)
Net income (loss) attributable to noncontrolling interest	(189,070)					(59)
Balances at end of period at Dec. 31, 2023	$ 405,153	$ 1,988	$ 4,342,362	$ (102,774)	$ (3,837,912)	$ 1,489
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Restricted stock and restricted stock units, net (in shares)		1,580,000
Shares withheld for employee taxes (in shares)		(576,000)
Balances at end of period (in shares) at Dec. 31, 2023	188,253,301	188,253,000